🇺🇸 FDA
Patent

US 10221223

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10221223 (Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory) held by The Regents of the University of California expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/1709